Germany
Japan
United Kingdom
China
Antibodies
View as table Download
ANK3 / ANKYRIN-G Goat Polyclonal Antibody
| Applications | IHC |
| Reactivities | Gorilla, Human, Monkey, Pig |
| Conjugation | Unconjugated |
| Immunogen | ANK3 / ANKYRIN-G antibody was raised against synthetic peptide C-SWQNETSSGNLE from an internal region of human ANK3 (NP_066267.2; NP_001140.2). Percent identity by BLAST analysis: Human, Gorilla, Monkey, Pig (100%); Orangutan, Gibbon, Elephant, Panda, Bovine, Dog, Horse (92%); Hamster, Bat, Rabbit (83%). |
GDF15 Goat Polyclonal (C-Terminus) Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Human |
| Conjugation | Unconjugated |
| Immunogen | GDF15 antibody was raised against synthetic peptide C-QKTDTGVSLQTYDD from the C-terminus of human GDF15 (NP_004855.2). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey (100%); Marmoset (93%). |
Goat Polyclonal Anti-ROR1 Antibody
| Applications | IHC |
| Reactivities | Human (Expected from sequence similarity: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-ROR1 Antibody: Peptide with sequence C-GNKSQKPYKIDSKQA, from the C-Terminus (near) of the protein sequence according to NP_005003.2. |
Goat Polyclonal Anti-Rab11 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Rat, Mousse, Canine, Monkey |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptides derived from within residues 110 aa to the C-terminus of mouse Rab11a, Rab11b and Rab11c (Rab25) produced in E. coli. |
Goat Polyclonal Anti-Rab27 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 120 aa to the C-terminus of mouse Rab27a and rab27b produced in E. coli. |
Complement C3 (C3) goat polyclonal antibody, TRITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | TRITC |
| Immunogen | C3c is isolated and purified from pooled normal human serum. Freund’s complete adjuvant is used in the first step of the immunization. |
Complement C5 (C5) goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | FITC |
| Immunogen | C5 protein isolated and purified from pooled normal human serum. Freund’s complete adjuvant is used in the first step of the immunization |
Lactoferrin (LTF) goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | FITC |
| Immunogen | The immunogen has been isolated from human milk. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
HNF 4 alpha (HNF4A) (2-15) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Bat, Canine, Equine, Hamster, Human, Monkey, Porcine, Rabbit |
| Immunogen | Synthetic peptide from the N-terminus of human HNF4A / HNF4 (NP_849180.1; NP_000448.3; NP_849181.1) |
Hsp60 (HSPD1) goat polyclonal antibody, Purified
| Applications | IHC, IP, WB |
| Reactivities | Bacteria, Bovine, Canine, Drosophila, Fish, Guinea Pig, Hamster, Human, Monkey, Mouse, Porcine, Rabbit, Rat, Sheep, Xenopus |
| Immunogen | HSPD1 antibody was raised against recombinant human HSP60. |
SLC12A1 (43-57) goat polyclonal antibody, Aff - Purified
| Applications | IHC |
| Reactivities | Human, Monkey |
| Immunogen | Synthetic peptide from positions 43-57 of human SLC12A1 (NP_000329.2) |
IL6 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human |
| Immunogen | Highly pure (> 98%), 20.9 kDa E.coli derived recombinant Human IL-6 |
IL6 goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human |
| Immunogen | Highly pure (> 98%), 20.9 kDa E.coli derived recombinant Human IL-6 |
Goat Anti-ANILLIN / Scraps (C Terminus) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence WQPDACYKPIGKP, from the C Terminus of the protein sequence according to NP_061155.2. |
Goat Anti-MDG1 / DNAJB9 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence RGNMVTTYTDCSGQ, from the C Terminus of the protein sequence according to NP_036460.1. |
GLUD1 Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Gibbon, Chimpanzee, Gorilla, Horse, Human, Monkey, Mouse, Orang-Utan, Pig |
| Conjugation | Unconjugated |
| Immunogen | GLUD1/Glutamate Dehydrogenase antibody was raised against synthetic peptide C-ESEEQKRNRVRGILR from an internal region of human GLUD1 (NP_005262.1; NP_036216.2). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Monkey, Marmoset, Mouse, Panda, Horse, Pig (100%); Rat, Opossum, Pufferfish (93%); Bovine, Xenopus, Stickleback (87%). |
HRH1 / H1 Receptor Goat Polyclonal (C-Terminus) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Chimpanzee, Gorilla, Human, Orang-Utan |
| Conjugation | Unconjugated |
| Immunogen | HRH1 / Histamine H1 Receptor antibody was raised against synthetic peptide CNENFKKTFKRILH from the C-terminus of human HRH1 / Histamine H1 Receptor (NP_000852.1; NP_001091681.1; NP_001091682.1; NP_001091683.1). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Bat, Platypus (100%); Monkey, Mouse, Rat, Dog, Bovine, Hamster, Elephant, Panda, Rabbit, Horse, Pig, Turkey, Chicken (93%); Marmoset, Guinea pig, Xenopus (86%). |
APOH / Apolipoprotein H Goat Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | APOH / Apolipoprotein H antibody was raised against human beta2-Glycoprotein-I (beta2GP-I) purified from plasma. |
Anti-NR1I2 Goat Polyclonal Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Human |
| Conjugation | Unconjugated |
| Immunogen | NR1I2 / PXR / PAR antibody was raised against synthetic peptide EQFAITLKSYIECNR from an internal region of human NR1I2 / PXR (NP_003880.3; NP_071285.1; NP_148934.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon (100%); Monkey, Marmoset (93%); Horse, Pig (87%); Panda, Dog, Rabbit (80%). |
Goat Polyclonal Anti-PEX13 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-PEX13 Antibody: Peptide with sequence C-DSIGKDGEKQDL, from the C Terminus of the protein sequence according to NP_002609.1. |
Collagen V (COL5A1) goat polyclonal antibody, Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human |
| Immunogen | Human type V collagen |
Complement factor B (CFB) goat polyclonal antibody, Serum
| Applications | ID, IHC, IP |
| Reactivities | Human |
| Immunogen | Isolated as a homogenous protein for use in antiserum production. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
NLRP3 (C-term) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Bovine, Human, Rat |
| Immunogen | synthetic peptide corresponding to the C-Terminus of the protein sequence according to NP_001073289.1; NP_004886.3; NP_899632.1; NP_001120933.1; NP_001120934.1. |
Plexin D1 (PLXND1) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Bovine, Canine, Human, Porcine |
| Immunogen | Peptide with sequence C-LAEPKKSHRQSH, from the internal region of the protein sequence according to NP_055918.2. |
Von Willebrand Factor (VWF) goat polyclonal antibody, Purified
| Applications | ELISA, Ie, IHC |
| Reactivities | Human |
| Immunogen | Human von Willebrand Factor (vWF) purified from plasma |
Leptin Receptor (LEPR) (829-841) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Immunogen | Synthetic peptide C-TQDDIEKHQSDAG from an internal region of human LEPR / Leptin Receptor (NP_002294.2; NP_001003679.1; NP_001003680.1). aa829-841 |
Active filters
Applications
- IHC
Antibody Hosts
- Goat
Families
- Druggable Genome
Filter by
Category
Target Symbol
- LTF (8)
- C3 (5)
- RAB27A (5)
- FMR1 (3)
- HMGA1 (3)
- IL17A (3)
- PLIN1 (3)
- RAB11A (3)
- AIF1 (2)
- AIRE (2)
- AKT3 (2)
- ALOX5AP (2)
- ALS2 (2)
- APEX1 (2)
- APOA1 (2)
- APOB (2)
- APOH (2)
- BAG3 (2)
- BDNF (2)
- CARD11 (2)
- CCL20 (2)
- CMA1 (2)
- CPT1B (2)
- CTSD (2)
- CXCL12 (2)
- CYBB (2)
- CYP26B1 (2)
- DCTN1 (2)
- DSG1 (2)
- EDF1 (2)
- ENPP1 (2)
- ETFB (2)
- F2R (2)
- FANCG (2)
- FGA (2)
- FTH1 (2)
- FZD2 (2)
- G6PD (2)
- GABRB3 (2)
- GHRL (2)
- GLUD1 (2)
- GPX1 (2)
- GPX4 (2)
- GRB2 (2)
- HNF4A (2)
- HRH1 (2)
- IL6 (2)
- KMT2B (2)
- LEPR (2)
- MSX1 (2)
- MYB (2)
- PCK1 (2)
- PCSK6 (2)
- PDE4D (2)
- PPP4C (2)
- PTBP1 (2)
- PTCH1 (2)
- RNF34 (2)
- ROR1 (2)
- SERPINE1 (2)
- SFRP1 (2)
- SLC25A47 (2)
- SRD5A1 (2)
- TAB2 (2)
- TIA1 (2)
- TNS1 (2)
- TSPO (2)
- TXNDC5 (2)
- UBR5 (2)
- UCP2 (2)
- WNT3 (2)
- ABCA9 (1)
- ABCB9 (1)
- ABCC11 (1)
- ABCC4 (1)
- ABCD4 (1)
- ACADM (1)
- ACKR1 (1)
- ACPP (1)
- ACVR1 (1)
- ADAM19 (1)
- ADGRA3 (1)
- ADORA2B (1)
- AHR (1)
- AIFM2 (1)
- AKR1A1 (1)
- ALDH3A2 (1)
- ALDH5A1 (1)
- ALDH6A1 (1)
- ALDH9A1 (1)
- ANK3 (1)
- ANLN (1)
- ANTXR2 (1)
- ANXA1 (1)
- APH1A (1)
- APOC3 (1)
- AR (1)
- ARHGAP26 (1)
- ARIH1 (1)
- AS3MT (1)
Reactivities
Isotypes
Clonalities
Conjugates
Pathways
- Pathways in cancer (36)
- Metabolic pathways (34)
- Cytokine-cytokine receptor interaction (25)
- Neuroactive ligand-receptor interaction (20)
- MAPK signaling pathway (19)
- Chemokine signaling pathway (18)
- Wnt signaling pathway (18)
- Complement and coagulation cascades (17)
- Focal adhesion (17)
- Toll-like receptor signaling pathway (17)
- Jak-STAT signaling pathway (15)
- Regulation of actin cytoskeleton (15)
- Adipocytokine signaling pathway (14)
- Colorectal cancer (14)
- PPAR signaling pathway (14)
- Insulin signaling pathway (13)
- T cell receptor signaling pathway (13)
- Endocytosis (12)
- Prostate cancer (12)
- B cell receptor signaling pathway (11)
- Calcium signaling pathway (11)
- Leukocyte transendothelial migration (11)
- Acute myeloid leukemia (10)
- Basal cell carcinoma (10)
- Natural killer cell mediated cytotoxicity (10)
- Neurotrophin signaling pathway (10)
- Axon guidance (9)
- NOD-like receptor signaling pathway (9)
- Apoptosis (8)
- Arginine and proline metabolism (8)
- Endometrial cancer (8)
- ErbB signaling pathway (8)
- Fc epsilon RI signaling pathway (8)
- Huntington's disease (8)
- Melanogenesis (8)
- Renal cell carcinoma (8)
- Systemic lupus erythematosus (8)
- Type I diabetes mellitus (8)
- Glioma (7)
- Glutathione metabolism (7)
- Hypertrophic cardiomyopathy (HCM) (7)
- Melanoma (7)
- Non-small cell lung cancer (7)
- Progesterone-mediated oocyte maturation (7)
- Adherens junction (6)
- Alanine (6)
- Amyotrophic lateral sclerosis (ALS) (6)
- Arachidonic acid metabolism (6)
- Butanoate metabolism (6)
- Chronic myeloid leukemia (6)
- Fatty acid metabolism (6)
- Fc gamma R-mediated phagocytosis (6)
- Hematopoietic cell lineage (6)
- Pancreatic cancer (6)
- TGF-beta signaling pathway (6)
- Tight junction (6)
- VEGF signaling pathway (6)
- aspartate and glutamate metabolism (6)
- mTOR signaling pathway (6)
- ABC transporters (5)
- Allograft rejection (5)
- Base excision repair (5)
- ECM-receptor interaction (5)
- Gap junction (5)
- Glycolysis / Gluconeogenesis (5)
- Graft-versus-host disease (5)
- Oocyte meiosis (5)
- Purine metabolism (5)
- Small cell lung cancer (5)
- Ubiquitin mediated proteolysis (5)
- beta-Alanine metabolism (5)
- p53 signaling pathway (5)
- Alzheimer's disease (4)
- Bladder cancer (4)
- Cell cycle (4)
- Dilated cardiomyopathy (4)
- Glycerolipid metabolism (4)
- Hedgehog signaling pathway (4)
- Lysosome (4)
- Nitrogen metabolism (4)
- Propanoate metabolism (4)
- Pyruvate metabolism (4)
- RIG-I-like receptor signaling pathway (4)
- Tryptophan metabolism (4)
- Valine (4)
- leucine and isoleucine degradation (4)
- Androgen and estrogen metabolism (3)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (3)
- Autoimmune thyroid disease (3)
- Citrate cycle (TCA cycle) (3)
- Dorso-ventral axis formation (3)
- GnRH signaling pathway (3)
- Histidine metabolism (3)
- Inositol phosphate metabolism (3)
- Long-term depression (3)
- Maturity onset diabetes of the young (3)
- Notch signaling pathway (3)
- Phosphatidylinositol signaling system (3)
- Primary immunodeficiency (3)
- Prion diseases (3)
- Renin-angiotensin system (3)
- Retinol metabolism (3)
- Riboflavin metabolism (3)
- Type II diabetes mellitus (3)
- Tyrosine metabolism (3)
- Vascular smooth muscle contraction (3)
- Ascorbate and aldarate metabolism (2)
- Cell adhesion molecules (CAMs) (2)
- Cytosolic DNA-sensing pathway (2)
- D-Glutamine and D-glutamate metabolism (2)
- Limonene and pinene degradation (2)
- Long-term potentiation (2)
- Lysine degradation (2)
- Nicotinate and nicotinamide metabolism (2)
- Non-homologous end-joining (2)
- Pantothenate and CoA biosynthesis (2)
- Parkinson's disease (2)
- Pathogenic Escherichia coli infection (2)
- Pentose phosphate pathway (2)
- Porphyrin and chlorophyll metabolism (2)
- Starch and sucrose metabolism (2)
- Taurine and hypotaurine metabolism (2)
- Vibrio cholerae infection (2)
- Amino sugar and nucleotide sugar metabolism (1)
- Antigen processing and presentation (1)
- Asthma (1)
- Cardiac muscle contraction (1)
- Cysteine and methionine metabolism (1)
- Drug metabolism - cytochrome P450 (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Fatty acid biosynthesis (1)
- Glycine (1)
- Glycosaminoglycan degradation (1)
- Methane metabolism (1)
- Mismatch repair (1)
- Nucleotide excision repair (1)
- Olfactory transduction (1)
- One carbon pool by folate (1)
- Pentose and glucuronate interconversions (1)
- Phenylalanine metabolism (1)
- Primary bile acid biosynthesis (1)
- Proteasome (1)
- Pyrimidine metabolism (1)
- RNA degradation (1)
- SNARE interactions in vesicular transport (1)
- Synthesis and degradation of ketone bodies (1)
- Taste transduction (1)
- Thyroid cancer (1)
- Viral myocarditis (1)
- serine and threonine metabolism (1)